Search
for
Sort by
Research 31–60 of 401
- Dermatological adverse events with taxane chemotherapy
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Cutaneous Reactions to Chemotherapeutic Agents
- Skin toxicity of anti‐cancer therapy
- Cutaneous angiosarcoma of the face and scalp presenting as alopecia
- Alopecia and Hair Damage Induced by Oncological Therapy
- Prostate cancer update: 2007
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
- Melatonin protects K15+ human hair follicle stem cells and hair matrix keratinocytes against paclitaxel-induced damage ex vivo
- Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question
- 636 Treatment of central centrifugal cicatricial alopecia with oral minoxidil
- 化療掉髮:頭皮冷凍帽(scalp cooling)真的有效嗎?
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- VIJAYA-The one who fights to win
- Alopécia Permanente Pós-Quimioterapia com Resposta Favorável ao Minoxidil Tópico
- Multiple drugs
- Index
- 203 Inhibin A is downregulated during chemotherapy in patients with breast cancer
- Ki-67 Levels and Their Association With Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Prospective Observational Study
- Patient-reported Outcomes of Adverse Events After Perioperative Chemotherapy for Breast Cancer: A Prospective Observational Study
- Patient-reported outcomes of adverse events after perioperative chemotherapy for breast cancer: A prospective observational study